Fetal Demise: Clinical Trials

5 trials for Fetal Demise, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 terminated. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Terminated 1
Phase 41Completed 1

Follow Fetal Demise: new trials by email Literature Review of Fetal Demise trials Research Report on Fetal Demise

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial
Mifepristone, Misoprostol - Abortion, Second Trimester, PPROM
Phase 4CompletedWashington University School of Medicine302022-07-012026-04-07
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Fetal Magnetocardiogram and Neonatal Electrocardiogram, Substudy only: Maternal/Infant Pharmacogenomic assessment postnatally - High Risk Pregnancy, Congenital Heart Disease
RecruitingMedical College of Wisconsin302018-07-012026-03-04
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
enoxaparin - Fetal Demise, Fetal Growth Restriction
Not applicableCompletedHaEmek Medical Center, Israel1442009-07-012016-02-23
MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure
Misoprostol and placebo, Mifepristone and misoprostol - Early Pregnancy Failure, Miscarriage
Not applicableTerminatedBoston University162007-04-012011-07-21
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
Recurrent Pregnancy Loss, Fetal Demise
CompletedUniversity of Chicago142005-03-012016-11-01

Narrower conditions

Fetal Death (5)  ·  Abortion, Habitual (1)  ·  Abortion, Spontaneous (1)  ·  Abruptio Placentae (1)  ·  Brugada Syndrome (1)  ·  Congenital Abnormalities (1)  ·  Fetal Growth Retardation (1)  ·  Fetofetal Transfusion (1)  ·  Gastroschisis (1)  ·  Heart Defects, Congenital (1)  ·  Hydrops Fetalis (1)  ·  Long QT Syndrome (1)  ·  Pre-Eclampsia (1)  ·  Pregnancy Complications (1)  ·  Preterm Premature Rupture of the Membranes (1)

Broader conditions

Death (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Urogenital Diseases (5)  ·  Pregnancy Complications (4)  ·  Cardiovascular Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Fetal Diseases (2)  ·  Pathological Conditions, Anatomical (2)  ·  Abortion, Spontaneous (1)  ·  Anemia (1)  ·  Anemia, Neonatal (1)  ·  Arrhythmias, Cardiac (1)  ·  Cardiac Conduction System Disease (1)

Interventions

Mifepristone (2)  ·  Misoprostol (2)  ·  Enoxaparin (1)

Sponsors

Boston University (1)  ·  HaEmek Medical Center, Israel (1)  ·  Medical College of Wisconsin (1)  ·  University of Chicago (1)  ·  Washington University School of Medicine (1)

Countries

United States (4)  ·  Israel (1)

Top investigators

Janette F Strasburger, MD (1)  ·  Mary D. Stephenson, MD, MSc (1)  ·  Olivera Vragovic, MBA (1)  ·  Raed Salim, MD (1)  ·  Sarah J Betstadt, MD (1)

Results publications

PMID 27440463, PMID 33779986

NIH funding

R01HL143485 (1)